Sex differences in physiological progression of idiopathic pulmonary fibrosis. Academic Article uri icon

Overview

MeSH

  • Cohort Studies
  • Disease Progression
  • Exercise Test
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pulmonary Diffusing Capacity
  • Sex Factors
  • Survival Analysis
  • Vital Capacity

MeSH Major

  • Exercise Tolerance
  • Hypoxia
  • Pulmonary Fibrosis

abstract

  • In idiopathic pulmonary fibrosis, incidence is higher in males, and females may have better survival. The aim of the present study was to determine whether the rate of increase in desaturation during serial 6-min walk testing would be greater, and survival worse, for males versus females. Serial changes in the percentage of maximum desaturation area (DA) over 1 yr were estimated using mixed models in 215 patients. DA was defined as the total area above the curve created using desaturation percentage values observed during each minute of the 6-min walk test. Multivariate Cox regression assessed survival differences. Adjusting for baseline DA, 6-min walk distance, change in 6-min walk distance over time and smoking history, the percentage of maximum DA increased by an average of 2.83 and 1.37% per month for males and females, respectively. Females demonstrated better survival overall, which was more pronounced in patients who did not desaturate below 88% on ambulation at baseline and after additionally adjusting for 6-month relative changes in DA and forced vital capacity. These data suggest that differences in disease progression contribute to, but do not completely explain, better survival of females with idiopathic pulmonary fibrosis.

publication date

  • June 2008

has subject area

  • Cohort Studies
  • Disease Progression
  • Exercise Test
  • Exercise Tolerance
  • Female
  • Humans
  • Hypoxia
  • Male
  • Middle Aged
  • Pulmonary Diffusing Capacity
  • Pulmonary Fibrosis
  • Sex Factors
  • Survival Analysis
  • Vital Capacity

Research

keywords

  • Journal Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1183/09031936.00165207

PubMed ID

  • 18321929

Additional Document Info

start page

  • 1183

end page

  • 1188

volume

  • 31

number

  • 6